BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14602213)

  • 1. C-reactive protein on admission and the success of thrombolytic therapy with streptokinase: is there any relation?
    Amasyali B; Kose S; Kilic A; Iyisoy A; Barcin C; Kursaklioglu H; Barindik N; Tokgoz S; Isik E; Demirtas E
    Int J Cardiol; 2003 Nov; 92(1):27-33. PubMed ID: 14602213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein.
    Kurt IH; Batur MK; Unal I
    Anadolu Kardiyol Derg; 2011 Sep; 11(6):530-5. PubMed ID: 21821500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of thrombolytic therapy on C-reactive protein in ST-segment elevation acute myocardial infarction.
    Tsakiris AK; Marnelos PG; Nearchou NS; Papadakis JE; Karatzis EN; Skoufas PD
    Hellenic J Cardiol; 2006; 47(4):218-22. PubMed ID: 16897925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
    Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
    Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
    Amos DJ; French JK; Andrews J; Ashton NG; Williams BF; Whitlock RM; Manda SO; White HD
    Am Heart J; 2001 Apr; 141(4):586-91. PubMed ID: 11275924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
    Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR
    Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
    Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
    Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.
    French JK; Hyde TA; Patel H; Amos DJ; McLaughlin SC; Webber BJ; White HD
    J Am Coll Cardiol; 1999 Jul; 34(1):62-9. PubMed ID: 10399993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.
    Juliard JM; Himbert D; Cristofini P; Desportes JC; Magne M; Golmard JL; Aubry P; Benamer H; Boccara A; Karrillon GJ; Steg PG
    Am J Cardiol; 1999 Feb; 83(3):305-10. PubMed ID: 10072213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of lipoprotein-a on thrombolytic therapy and spontaneous reperfusion in acute myocardial infarction. A comparative study.
    Dagdelen S; Eren N; Akdemir I; Karabulut H; Ergelen M; Caglar N
    Int Angiol; 2002 Dec; 21(4):384-9. PubMed ID: 12518121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.
    de Boer MJ; Reiber JH; Suryapranata H; van den Brand MJ; Hoorntje JC; Zijlstra F
    Eur Heart J; 1995 Oct; 16(10):1347-55. PubMed ID: 8746902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete recanalization as an important determinant of Thrombolysis in Myocardial Infarction (TIMI) grade 2 flow after thrombolytic therapy for acute myocardial infarction. TEAM Investigators. Thrombolytic Trial of Eminase in Acute Myocardial Infarction.
    Zahger D; Karagounis LA; Cercek B; Anderson JL; Sorensen S; Moreno F; Shah PK
    Am J Cardiol; 1995 Oct; 76(11):749-52. PubMed ID: 7572648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
    Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P
    J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.
    Ribeiro EE; Silva LA; Carneiro R; D'Oliveira LG; Gasquez A; Amino JG; Tavares JR; Petrizzo A; Torossian S; Duprat Filho R
    J Am Coll Cardiol; 1993 Aug; 22(2):376-80. PubMed ID: 8335807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis.
    Ziakas A; Gavrilidis S; Giannoglou G; Souliou E; Gemitzis K; Kalampalika D; Vayona MA; Pidonia I; Parharidis G; Louridas G
    Angiology; 2006; 57(3):283-93. PubMed ID: 16703188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.